Substrates for peptidase S01.231: urokinase-type plasminogen activator
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ac-Ala-Ser-Gly-Lys-ACC | Ac-Ala-Ser-Gly-Lys+ACC | S | Ala | Ser | Gly | Lys | ACC | - | - | - | Gosalia et al., 2005 | |||||
| Ac-Ala-Thr-Ser-Lys-ACC | Ac-Ala-Thr-Ser-Lys+ACC | S | Ala | Thr | Ser | Lys | ACC | - | - | - | Gosalia et al., 2005 | |||||
| aggrecan core protein | P16112 | 17-2415 | peptide-Val397+Ile-peptide | P | Arg | Gly | Ser | Val | Ile | Leu | Thr | Val | Fosang et al., 1998 | 18241 | ||
| Boc-Leu-Gly-Arg-NHMec | Boc-Leu-Gly-Arg+NHMec | S | Boc | Leu | Gly | Arg | AMC | - | - | - | ||||||
| Glp-Gly-Arg-NHPhNO2 | Glp-Gly-Arg+NHPhNO2 | S | - | Glp | Gly | Arg | NAN | - | - | - | Ellis, 2004 | |||||
| Glt-Gly-Arg-NHMec | Glt-Gly-Arg+NHMec | S | - | Glt | Gly | Arg | AMC | - | - | - | Ellis, 2004 | |||||
| Hepatocyte growth factor | P14210 | 32-728 | Peptide-Arg494+Val-Peptide | P | MU | Lys | Gln | Leu | Arg | Val | Val | Asn | Gly | Mars et al., 1993 | ||
| hyaluronan-binding peptidase | Q14520 | 24-560 | peptide-Arg313+Ile-peptide | N | Lys | Ile | Lys | Arg | Ile | Tyr | Gly | Gly | Kannemeier et al., 2001 | |||
| integrin alpha-6 | P23229 | 24-1130 | peptide-Arg633+Arg-peptide | P | Pro | Ser | Ser | Arg | Arg | Arg | Val | Asn | Pawar et al., 2007 | 22055 | ||
| plasminogen | P00747 | 20-810 | peptide-Arg560+Val-peptide | P | Cys | Pro | Gly | Arg | Val | Val | Gly | Gly | Robbins et al., 1967 | 17423 | ||
| S-2444 | D-Glu-Gly-Arg+NHPhNO2 | S | - | DGl | Gly | Arg | NAN | - | - | - | Amarant et al., 1991 | |||||
| small-inducible cytokine A14 precursor | Q16627 | 20-93 | peptide-Arg27+Gly-peptide | P | Ser | Ser | Ser | Arg | Gly | Pro | Tyr | His | Vakili et al., 2001 | |||
| upain-2 | Cys-Ser-Trp-Arg+Gly-Leu-Glu-Asn-His-Ala-Ala-Cys | S | Cys | Ser | Trp | Arg | Gly | Leu | Glu | Asn | Jiang et al., 2018 | |||||
| upain-2(Trp3Ala,Arg4guanidinoPhe) | Cys-Ser-Ala-4-guanidinoPhe+Gly-Leu-Glu-Asn-His-Ala-Ala-Cys | S | Cys | Ser | Ala | Gnf | Gly | Leu | Glu | Asn | Jiang et al., 2018 | |||||
| urokinase plasminogen activator surface receptor | P35456 | 24-298 | peptide-Arg107+Gly-peptide | P | Pro | Gly | Ala | Arg | Gly | Arg | Ala | Phe | Andolfo et al., 2002 | 19936 | ||
| urokinase plasminogen activator surface receptor | Q03405 | 23-305 | peptide-Arg105+Ala-peptide | P | Asn | Ser | Gly | Arg | Ala | Val | Thr | Tyr | Andolfo et al., 2002 | 17425 | ||
| urokinase plasminogen activator surface receptor | Q03405 | 23-305 | peptide-Arg111+Ser-peptide | P | Thr | Tyr | Ser | Arg | Ser | Arg | Tyr | Leu | Andolfo et al., 2002 | 19565 | ||
| urokinase-type plasminogen activator | P00749 | 21-431 | peptide-Lys23+Tyr-peptide | P | Val | Ser | Asn | Lys | Tyr | Phe | Ser | Asn | Ellis, 2004 | 17424 | ||
| Z-Lys-SBzl | Z-Lys+SBzl | S | - | - | Z | Lys | SBz | - | - | - | Ellis, 2004 |
